We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Arcutis Biotherapeutics
ARQT
$3.38B
| $4.47M | ﹤0.01% |
170,542
+9,411
| +6% | +$219K |
|
1527
Viking Therapeutics
VKTX
$4.15B
| $4.46M | ﹤0.01% |
114,211
-5,891
| -5% | -$190K |
|
1528
Payoneer
PAYO
$2.43B
| $4.45M | ﹤0.01% |
625,568
-139,770
| -18% | -$765K |
|
1529
Blue Owl Capital
OWL
$6.37B
| $4.43M | ﹤0.01% |
506,195
-162,061
| -24% | -$1.54M |
|
1530
Towne Bank
TOWN
$3.36B
| $4.42M | ﹤0.01% |
121,842
+4,798
| +4% | +$168K |
|
1531
Sarepta Therapeutics
SRPT
$1.97B
| $4.39M | ﹤0.01% |
244,338
+41,268
| +20% | +$781K |
|
1532
Triumph Financial Inc
TFIN
$1.47B
| $4.39M | ﹤0.01% |
57,465
-5,746
| -9% | -$391K |
|
1533
Fortrea Holdings
FTRE
$1.89B
| $4.38M | ﹤0.01% |
251,965
+14,497
| +6% | +$196K |
|
1534
Scorpio Tankers
STNG
$4.08B
| $4.38M | ﹤0.01% |
63,213
+1,746
| +3% | +$137K |
|
|
KEEL
1535
Keel Infrastructure Corp
KEEL
$2.35B
| $4.37M | ﹤0.01% |
+760,513
| New | +$3.27M |
|
1536
Zillow
Z
$6.39B
| $4.36M | ﹤0.01% |
138,467
-41,027
| -23% | -$1.58M |
|
|
STEL
1537
DELISTED
Stellar Bancorp
STEL
| $4.35M | ﹤0.01% |
110,577
-17,351
| -14% | -$653K |
|
1538
Harmonic Inc
HLIT
$1.2B
| $4.34M | ﹤0.01% |
265,533
-48,774
| -16% | -$622K |
|
1539
Pinduoduo
PDD
$110B
| $4.33M | ﹤0.01% |
56,762
-8,825
| -13% | -$815K |
|
1540
SAP
SAP
$243B
| $4.32M | ﹤0.01% |
28,060
+862
| +3% | +$147K |
|
|
HNGE
1541
Hinge Health
HNGE
$7.71B
| $4.31M | ﹤0.01% |
+51,969
| New | +$2.82M |
|
1542
Hilltop Holdings
HTH
$2.21B
| $4.28M | ﹤0.01% |
110,364
-16,574
| -13% | -$623K |
|
1543
Adaptive Biotechnologies
ADPT
$4.7B
| $4.28M | ﹤0.01% |
199,336
+16,464
| +9% | +$252K |
|
1544
Winmark
WINA
$1.06B
| $4.24M | ﹤0.01% |
10,014
-752
| -7% | -$294K |
|
1545
Delek US
DK
$4.15B
| $4.23M | ﹤0.01% |
83,165
+1,237
| +2% | +$54.9K |
|
1546
Kemper
KMPR
$1.49B
| $4.2M | ﹤0.01% |
155,603
+3,321
| +2% | +$96.7K |
|
1547
ImmunityBio
IBRX
$8.95B
| $4.18M | ﹤0.01% |
476,935
+114,880
| +32% | +$870K |
|
1548
Credicorp
BAP
$30.7B
| $4.17M | ﹤0.01% |
10,716
-385
| -3% | -$132K |
|
1549
Shell
SHEL
$273B
| $4.17M | ﹤0.01% |
53,782
+8,245
| +18% | +$712K |
|
1550
IDEAYA Biosciences
IDYA
$3.54B
| $4.17M | ﹤0.01% |
111,764
+4,381
| +4% | +$134K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.